132 research outputs found
Comprehensive simulations of superhumps
(Abridged) We use 3D SPH calculations with higher resolution, as well as with
more realistic viscosity and sound-speed prescriptions than previous work to
examine the eccentric instability which underlies the superhump phenomenon in
semi-detached binaries. We illustrate the importance of the two-armed spiral
mode in the generation of superhumps. Differential motions in the fluid disc
cause converging flows which lead to strong spiral shocks once each superhump
cycle. The dissipation associated with these shocks powers the superhump. We
compare 2D and 3D results, and conclude that 3D simulations are necessary to
faithfully simulate the disc dynamics. We ran our simulations for unprecedented
durations, so that an eccentric equilibrium is established except at high mass
ratios where the growth rate of the instability is very low. Our improved
simulations give a closer match to the observed relationship between superhump
period excess and binary mass ratio than previous numerical work. The observed
black hole X-ray transient superhumpers appear to have systematically lower
disc precession rates than the cataclysmic variables. This could be due to
higher disc temperatures and thicknesses. The modulation in total viscous
dissipation on the superhump period is overwhelmingly from the region of the
disc within the 3:1 resonance radius. As the eccentric instability develops,
the viscous torques are enhanced, and the disc consequently adjusts to a new
equilibrium state, as suggested in the thermal-tidal instability model. We
quantify this enhancement in the viscosity, which is ~10 per cent for q=0.08.
We characterise the eccentricity distributions in our accretion discs, and show
that the entire body of the disc partakes in the eccentricity.Comment: 18 pages (mn2e LaTeX), 14 figures, 5 tables, Accepted for publication
in MNRA
Determinants of exercise intolerance in breast cancer patients prior to anthracycline chemotherapy
Women with early‐stage breast cancer have reduced peak exercise oxygen uptake (peak V O2). The purpose of this study was to evaluate peak V O2 and right (RV ) and left (LV ) ventricular function prior to adjuvant chemotherapy. Twenty‐nine early‐stage breast cancer patients (mean age: 48 years) and 10 age‐matched healthy women were studied. Participants performed an upright cycle exercise test with expired gas analysis to measure peak V O2. RV and LV volumes and function were measured at rest, submaximal and peak supine cycle exercise using cardiac magnetic resonance imaging. Peak V O2 was significantly lower in breast cancer patients versus controls (1.7 ± 0.4 vs. 2.3 ± 0.5 L/min, P = 0.0013; 25 ± 6 vs. 35 ± 6 mL/kg/min, P = 0.00009). No significant difference was found between groups for peak upright exercise heart rate (174 ± 13 vs. 169 ± 16 bpm, P = 0.39). Rest, submaximal and peak exercise RV and LV end‐diastolic and end‐systolic volume index, stroke index, and cardiac index were significantly lower in breast cancer patients versus controls (P < 0.05 for all). No significant difference was found between groups for rest and exercise RV and LV ejection fraction. Despite preserved RV and LV ejection fraction, the decreased peak V O2 in early‐stage breast cancer patients prior to adjuvant chemotherapy is due in part to decreased peak cardiac index secondary to reductions in RV and LV end‐diastolic volumes
Exercise attenuates cardiotoxicity of anthracycline chemotherapy measured by global longitudinal strain [Letter]
[Extract] Anthracycline-based chemotherapy (AC) is a common
treatment for patients with breast cancer and has
been associated with a dramatic improvement in
breast cancer survivorship. Among patients with
early-stage breast cancer, cardiovascular diseases
represent the most common cause of mortality, and
there is a growing emphasis on strategies for minimizing
the toxic effects of breast cancer treatments
on the cardiovascular system (1)
Exercise attenuates cardiotoxicity of anthracycline chemotherapy measured by global longitudinal strain [Letter]
[Extract] Anthracycline-based chemotherapy (AC) is a common
treatment for patients with breast cancer and has
been associated with a dramatic improvement in
breast cancer survivorship. Among patients with
early-stage breast cancer, cardiovascular diseases
represent the most common cause of mortality, and
there is a growing emphasis on strategies for minimizing
the toxic effects of breast cancer treatments
on the cardiovascular system (1)
Simulations of spectral lines from an eccentric precessing accretion disc
Two dimensional SPH simulations of a precessing accretion disc in a q=0.1
binary system (such as XTE J1118+480) reveal complex and continuously varying
shape, kinematics, and dissipation. The stream-disc impact region and disc
spiral density waves are prominent sources of energy dissipation.The dissipated
energy is modulated on the period P_{sh} = ({P_{orb}}^{-1}-{P_{prec}}^{-1}^{-1}
with which the orientation of the disc relative to the mass donor repeats. This
superhump modulation in dissipation energy has a variation in amplitude of ~10%
relative to the total dissipation energy and evolves, repeating exactly only
after a full disc precession cycle. A sharp component in the light curve is
associated with centrifugally expelled material falling back and impacting the
disc. Synthetic trailed spectrograms reveal two distinct "S-wave" features,
produced respectively by the stream gas and the disc gas at the stream-disc
impact shock. These S-waves are non-sinusoidal, and evolve with disc precession
phase. We identify the spiral density wave emission in the trailed spectrogram.
Instantaneous Doppler maps show how the stream impact moves in velocity space
during an orbit. In our maximum entropy Doppler tomogram the stream impact
region emission is distorted, and the spiral density wave emission is
uppressed. A significant radial velocity modulation of the whole line profile
occurs on the disc precession period. We compare our SPH simulation with a
simple 3D model: the former is appropriate for comparison with emission lines
while the latter is preferable for skewed absorption lines from precessing
discs.Comment: See http://physics.open.ac.uk/FHMR/ for associated movie (avi) files.
The full paper is in MNRAS press. Limited disk space limit of 650k, hence low
resolution figure file
Effects of a multicomponent resistance-based exercise program with protein, vitamin D and calcium supplementation on cognition in men with prostate cancer treated with ADT: Secondary analysis of a 12-month randomised controlled trial
OBJECTIVES: The aim of this preplanned secondary analysis of a 12-month randomised controlled trial was to investigate the effects of a multicomponent exercise programme combined with daily whey protein, calcium and vitamin D supplementation on cognition in men with prostate cancer treated with androgen deprivation therapy (ADT). DESIGN: 12-month, two-arm, randomised controlled trial. SETTING: University clinical exercise centre. PARTICIPANTS: 70 ADT-treated men were randomised to exercise-training plus supplementation (Ex+ Suppl, n=34) or usual care (control, n=36). INTERVENTION: Men allocated to Ex + Suppl undertook thrice weekly resistance training with weight-bearing exercise training plus daily whey protein (25 g), calcium (1200 mg) and vitamin D (2000 IU) supplementation. PRIMARY AND SECONDARY OUTCOME MEASURES: Cognition was assessed at baseline, 6 and 12 months via a computerised battery (CogState), Trail-making test, Rey auditory-verbal learning test and Digit span. Data were analysed with linear mixed models and an intention-to-treat and prespecified per-protocol approach (exercise-training: ≥ 66%, nutritional supplement: ≥ 80%). RESULTS: Sixty (86%) men completed the trial (Ex + Suppl, n = 31; control, n = 29). Five (7.1%) men were classified as having mild cognitive impairment at baseline. Median (IQR) adherence to the exercise and supplement was 56% (37%-82%) and 91% (66%-97%), respectively. Ex + Suppl had no effect on cognition at any time. CONCLUSIONS: A 12-month multicomponent exercise training and supplementation intervention had no significant effect on cognition in men treated with ADT for prostate cancer compared with usual care. Exercise training adherence below recommended guidelines does not support cognitive health in men treated with ADT for prostate cancer. TRIAL REGISTRATION NUMBER: Australian and New Zealand Clinical Trial Registry (ACTRN12614000317695, registered 25/03/2014) and acknowledged under the Therapeutic Goods Administration Clinical Trial Notification Scheme (CT-2015-CTN-03372-1 v1)
Expression and regulation of drug transporters in vertebrate neutrophils.
There remains a need to identify novel pro-resolution drugs for treatment of inflammatory disease. To date, there are no neutrophil-specific anti-inflammatory treatments in clinical use, perhaps due to our lack of understanding of how drugs access this complex cell type. Here we present the first comprehensive description and expression of both major classes of drug transporters, SLC and ABC, in resting human blood neutrophils. Moreover, we have studied the expression of these carriers in the tractable model system, the zebrafish (Danio rerio), additionally examining the evolutionary relationship between drug transporters in zebrafish and humans. We anticipate that this will be a valuable resource to the field of inflammation biology and will be an important asset in future anti-inflammatory drug design
Post hoc Analysis for Detecting Individual Rare Variant Risk Associations Using Probit Regression Bayesian Variable Selection Methods in Case-Control Sequencing Studies
Rare variants (RVs) have been shown to be significant contributors to complex disease risk. By definition, these variants have very low minor allele frequencies and traditional single-marker methods for statistical analysis are underpowered for typical sequencing study sample sizes. Multimarker burden-type approaches attempt to identify aggregation of RVs across case-control status by analyzing relatively small partitions of the genome, such as genes. However, it is generally the case that the aggregative measure would be a mixture of causal and neutral variants, and these omnibus tests do not directly provide any indication of which RVs may be driving a given association. Recently, Bayesian variable selection approaches have been proposed to identify RV associations from a large set of RVs under consideration. Although these approaches have been shown to be powerful at detecting associations at the RV level, there are often computational limitations on the total quantity of RVs under consideration and compromises are necessary for large-scale application. Here, we propose a computationally efficient alternative formulation of this method using a probit regression approach specifically capable of simultaneously analyzing hundreds to thousands of RVs. We evaluate our approach to detect causal variation on simulated data and examine sensitivity and specificity in instances of high RV dimensionality as well as apply it to pathway-level RV analysis results from a prostate cancer (PC) risk case-control sequencing study. Finally, we discuss potential extensions and future directions of this work
Clique-Finding for Heterogeneity and Multidimensionality in Biomarker Epidemiology Research: The CHAMBER Algorithm
Commonly-occurring disease etiology may involve complex combinations of genes and exposures resulting in etiologic heterogeneity. We present a computational algorithm that employs clique-finding for heterogeneity and multidimensionality in biomedical and epidemiological research (the "CHAMBER" algorithm).This algorithm uses graph-building to (1) identify genetic variants that influence disease risk and (2) predict individuals at risk for disease based on inherited genotype. We use a set-covering algorithm to identify optimal cliques and a Boolean function that identifies etiologically heterogeneous groups of individuals. We evaluated this approach using simulated case-control genotype-disease associations involving two- and four-gene patterns. The CHAMBER algorithm correctly identified these simulated etiologies. We also used two population-based case-control studies of breast and endometrial cancer in African American and Caucasian women considering data on genotypes involved in steroid hormone metabolism. We identified novel patterns in both cancer sites that involved genes that sulfate or glucuronidate estrogens or catecholestrogens. These associations were consistent with the hypothesized biological functions of these genes. We also identified cliques representing the joint effect of multiple candidate genes in all groups, suggesting the existence of biologically plausible combinations of hormone metabolism genes in both breast and endometrial cancer in both races.The CHAMBER algorithm may have utility in exploring the multifactorial etiology and etiologic heterogeneity in complex disease
Recommended from our members
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.
Breast cancer is a common disease partially caused by genetic risk factors. Germline pathogenic variants in DNA repair genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 are associated with breast cancer risk. FANCM, which encodes for a DNA translocase, has been proposed as a breast cancer predisposition gene, with greater effects for the ER-negative and triple-negative breast cancer (TNBC) subtypes. We tested the three recurrent protein-truncating variants FANCM:p.Arg658*, p.Gln1701*, and p.Arg1931* for association with breast cancer risk in 67,112 cases, 53,766 controls, and 26,662 carriers of pathogenic variants of BRCA1 or BRCA2. These three variants were also studied functionally by measuring survival and chromosome fragility in FANCM -/- patient-derived immortalized fibroblasts treated with diepoxybutane or olaparib. We observed that FANCM:p.Arg658* was associated with increased risk of ER-negative disease and TNBC (OR = 2.44, P = 0.034 and OR = 3.79; P = 0.009, respectively). In a country-restricted analysis, we confirmed the associations detected for FANCM:p.Arg658* and found that also FANCM:p.Arg1931* was associated with ER-negative breast cancer risk (OR = 1.96; P = 0.006). The functional results indicated that all three variants were deleterious affecting cell survival and chromosome stability with FANCM:p.Arg658* causing more severe phenotypes. In conclusion, we confirmed that the two rare FANCM deleterious variants p.Arg658* and p.Arg1931* are risk factors for ER-negative and TNBC subtypes. Overall our data suggest that the effect of truncating variants on breast cancer risk may depend on their position in the gene. Cell sensitivity to olaparib exposure, identifies a possible therapeutic option to treat FANCM-associated tumors
- …